|
US5206018A
(en)
*
|
1978-11-03 |
1993-04-27 |
Ayerst, Mckenna & Harrison, Inc. |
Use of rapamycin in treatment of tumors
|
|
IT1197485B
(it)
*
|
1986-10-07 |
1988-11-30 |
Boehringer Biochemia Srl |
Composizioni farmaceutiche ad attivita' antineoplastica
|
|
US5540931A
(en)
*
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
|
US20030068362A1
(en)
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US6749868B1
(en)
*
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6753006B1
(en)
*
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US20070122465A1
(en)
*
|
1993-02-22 |
2007-05-31 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US5665383A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
PT693924E
(pt)
*
|
1993-02-22 |
2004-09-30 |
American Biosciences |
Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
|
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US6528067B1
(en)
*
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US6096331A
(en)
*
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US5997904A
(en)
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US5362478A
(en)
*
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
EP1683517A1
(en)
|
1996-08-19 |
2006-07-26 |
American Bioscience, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
WO1998042330A1
(en)
*
|
1997-03-27 |
1998-10-01 |
Baker Norton Pharmaceuticals, Inc. |
Methods and compositions for treatment of ovarian cancer
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
CN100462066C
(zh)
*
|
1997-06-27 |
2009-02-18 |
美国生物科学有限公司 |
药剂的新制剂及其制备和应用方法
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
AU777528B2
(en)
|
1999-04-22 |
2004-10-21 |
Abraxis Bioscience, Llc |
Long term administration of pharmacologically active agents
|
|
EP1178786A4
(en)
|
1999-05-21 |
2006-03-01 |
American Bioscience Inc |
PHARMACOLOGICALLY ACTIVE PROTEIN STABILIZING AGENTS; METHODS OF MANUFACTURE AND METHODS OF USE
|
|
ITMI20001107A1
(it)
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
PL363991A1
(en)
|
2001-04-06 |
2004-11-29 |
Wyeth |
Antineoplastic combinations such as rapamycin together with gemcitabine or fluorouracil
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
CA2480809A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Children's Medical Center Corporation |
Methods for inhibiting vascular hyperpermeability
|
|
US20040126400A1
(en)
*
|
2002-05-03 |
2004-07-01 |
Iversen Patrick L. |
Delivery of therapeutic compounds via microparticles or microbubbles
|
|
NZ541142A
(en)
|
2002-12-09 |
2008-07-31 |
Abraxis Bioscience Inc |
Compositions and methods of delivery of pharmacological agents
|
|
DK1585548T3
(en)
|
2002-12-09 |
2018-09-03 |
Abraxis Bioscience Llc |
COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
|
|
WO2004060283A2
(en)
*
|
2002-12-16 |
2004-07-22 |
Nitromed, Inc. |
Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use
|
|
US20050119330A1
(en)
*
|
2003-03-17 |
2005-06-02 |
Kao Peter N. |
Use of antiproliferative agents in the treatment and prevention of pulmonary proliferative vascular diseases
|
|
US20050038498A1
(en)
*
|
2003-04-17 |
2005-02-17 |
Nanosys, Inc. |
Medical device applications of nanostructured surfaces
|
|
US20050152979A1
(en)
*
|
2003-09-05 |
2005-07-14 |
Cell Therapeutics, Inc. |
Hydrophobic drug compositions containing reconstitution enhancer
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
CN1980699B
(zh)
|
2004-05-14 |
2012-03-21 |
阿布拉西斯生物科学公司 |
利用白蛋白-结合蛋白作为靶标的治疗方法
|
|
WO2006039336A2
(en)
*
|
2004-10-01 |
2006-04-13 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
|
WO2006053754A1
(en)
|
2004-11-19 |
2006-05-26 |
Novartis Ag |
COMBINATIONS OF ANTI-ATHEROSCLEROTIC PEPTIDES AND AN mTOR INHIBITING AGENT AND THEIR METHODS OF USE
|
|
SG166775A1
(en)
|
2005-02-18 |
2010-12-29 |
Abraxis Bioscience Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
ES2663495T3
(es)
|
2005-02-18 |
2018-04-13 |
Abraxis Bioscience, Llc |
Fármacos con hidrofobicidad mejorada para incorporación en dispositivos médicos
|
|
CN101175481A
(zh)
*
|
2005-03-17 |
2008-05-07 |
伊兰制药国际有限公司 |
纳米颗粒免疫抑制化合物的可注射的组合物
|
|
US7514549B2
(en)
*
|
2005-04-16 |
2009-04-07 |
Michigan State University |
Tumor inhibition by modulating sprouty expression or activity
|
|
US20080214595A1
(en)
|
2005-05-16 |
2008-09-04 |
Seigo Izumo |
Use Of Rapamycin Derivatives For The Treatment And/Or Prevention Of Cardiovas Cular Disorders
|
|
US8034765B2
(en)
*
|
2005-08-31 |
2011-10-11 |
Abraxis Bioscience, Llc |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
HUE042678T2
(hu)
|
2005-08-31 |
2019-07-29 |
Abraxis Bioscience Llc |
Vízben rosszul oldódó gyógyszerhatóanyagok és antimikrobiális szerek
|
|
US20080280987A1
(en)
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
MX2009002054A
(es)
|
2006-08-31 |
2009-05-01 |
Abraxis Bioscience Llc |
Metodos para inhibir angiogenesis y tratamiento contra enfermedades asociadas con angiogenesis.
|
|
US20100112077A1
(en)
*
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
ITFI20060277A1
(it)
*
|
2006-11-08 |
2008-05-09 |
Giuliano Giustini |
Sollevatore per motociclette e simili, offrente mobilita' di spostamenti omnidirezionali
|
|
JP5933893B2
(ja)
*
|
2006-12-14 |
2016-06-15 |
アブラクシス バイオサイエンス， エルエルシー |
ホルモン受容体状態に基づいてタキサンを含むナノ粒子用いる乳癌治療法
|
|
CA3201293A1
(en)
|
2007-03-07 |
2008-09-12 |
Abraxis Bioscience, Llc |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
US20100166869A1
(en)
*
|
2007-05-03 |
2010-07-01 |
Desai Neil P |
Methods and compositions for treating pulmonary hypertension
|
|
AU2008260447B2
(en)
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
AU2009234127B2
(en)
*
|
2008-04-10 |
2015-04-30 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
EP2367425B1
(en)
*
|
2008-12-11 |
2018-02-28 |
Abraxis BioScience, LLC |
Combination therapy including a taxane and a further therapeutic agent
|
|
WO2010105172A1
(en)
*
|
2009-03-13 |
2010-09-16 |
Abraxis Bioscience, Llc |
Combination therapy with thiocolchicine derivatives
|
|
BRPI1014160A2
(pt)
*
|
2009-04-10 |
2015-08-25 |
Abraxis Bioscience Llc |
Formulações de nanopartículas e aplicações das mesmas
|
|
ME03596B
(me)
|
2009-04-15 |
2020-07-20 |
Abraxis Bioscience Llc |
Kompozicije nanočesтica bez priona i postupci povezani sa njima
|
|
SG178873A1
(en)
*
|
2009-08-25 |
2012-04-27 |
Abraxis Bioscience Llc |
Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
|
|
US9775819B2
(en)
*
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
|
US8269348B2
(en)
*
|
2010-02-22 |
2012-09-18 |
Texas Instruments Incorporated |
IC die including RDL capture pads with notch having bonding connectors or its UBM pad over the notch
|
|
HRP20160609T1
(hr)
*
|
2010-03-26 |
2016-09-23 |
Abraxis Bioscience, Llc |
Postupci liječenja hepatocelularnog karcinoma
|
|
CA2794147A1
(en)
*
|
2010-03-29 |
2011-10-06 |
Abraxis Bioscience, Llc |
Use of a composition comprising nanoparticles comprising a taxane and an albumin to improve uptake of chemotherapeutics by tumors and for treating a cancer that is highly fibrotic and/or has a dense stroma
|
|
KR101894689B1
(ko)
*
|
2010-03-29 |
2018-09-04 |
아브락시스 바이오사이언스, 엘엘씨 |
암의 치료 방법
|
|
WO2011153009A1
(en)
*
|
2010-06-02 |
2011-12-08 |
Abraxis Bioscience, Llc |
Methods of treating bladder cancer
|
|
EP2575804A4
(en)
*
|
2010-06-04 |
2013-10-23 |
Abraxis Bioscience Llc |
METHOD FOR THE TREATMENT OF PANCREASCRE
|
|
NZ707377A
(en)
*
|
2010-06-07 |
2015-09-25 |
Abraxis Bioscience Llc |
Combination therapy methods for treating proliferative diseases
|
|
US8871256B2
(en)
*
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
|
US9149455B2
(en)
*
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20140186447A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
US9511046B2
(en)
*
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
US20140199404A1
(en)
*
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of a nucleoside transporter
|
|
US20140199405A1
(en)
*
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on mutation status of k-ras
|